Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill (2016 - 2025)

Historic Goodwill for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $3.4 million.

  • Amphastar Pharmaceuticals' Goodwill rose 454.55% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 454.55%. This contributed to the annual value of $3.0 million for FY2024, which is 519.28% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Goodwill stood at $3.4 million for Q3 2025, which was up 454.55% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Goodwill ranged from a high of $3.8 million in Q2 2021 and a low of $2.9 million during Q3 2022
  • For the 5-year period, Amphastar Pharmaceuticals' Goodwill averaged around $3.3 million, with its median value being $3.2 million (2023).
  • Its Goodwill has fluctuated over the past 5 years, first plummeted by 2046.88% in 2022, then soared by 856.5% in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Goodwill (Quarter) stood at $3.3 million in 2021, then fell by 5.64% to $3.1 million in 2022, then rose by 2.88% to $3.2 million in 2023, then decreased by 5.19% to $3.0 million in 2024, then increased by 11.64% to $3.4 million in 2025.
  • Its Goodwill was $3.4 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.2 million in Q1 2025.